News 17 Jun 2026 DNDi and Medicines for Malaria Venture (MMV) pool regulatory expertise to accelerate access to lifesaving medicines
Stories 17 Jun 2026 The DNDi-MMV Joint Regulatory Platform: ‘a pioneering programme project for non-profit medical research organizations to speak with one voice’
Press Releases Translations 12 Jun 2026 La RDC approuve l’utilisation de l’acoziborole, un traitement oral à dose unique contre la maladie du sommeil
Press releases 12 Jun 2026 DRC approves the use of acoziborole, a breakthrough one-day oral treatment against sleeping sickness
Statements 9 Jun 2026 DNDi Statement at the UN Multi-Stakeholder Hearing on Pandemic Prevention, Preparedness, and Response (PPPR)
Press releases 8 Jun 2026 DNDi, GARDP, and MMV join forces to accelerate drug development for patients in greatest need
Scientific articles 5 Jun 2026 Severe visceral leishmaniasis in Ethiopia: Outcomes, co-infections and mortality in a prospective real-world cohort PLOS Neglected Tropical Diseases
Scientific articles 29 May 2026 From invisibility to political power: Policy lessons from a decade of Brazil’s Social Forum for Infectious and Neglected Diseases PLOS Neglected Tropical Diseases
Scientific articles 14 May 2026 In vitro profiling of Trypanosoma cruzi inhibitors identified from high throughput screening and application to parasite painting International Journal for Parasitology: Drugs and Drug Resistance
Statements 15 May 2026 DNDi statement on hantavirus outbreak: ‘Investment in pandemic preparedness efforts remains insufficient.’
Scientific articles 13 May 2026 Chemical genetics reveals Leishmania KKT2 and CRK9 kinase activity is required for cell cycle progression PLOS Pathogens
Press releases 12 May 2026 DNDi welcomes GHIT support for global evaluation and registration of fosravuconazole for eumycetoma, in collaboration with Eisai
In the media 29 Apr 2026 Thailand approves ravidasvir, a new drug for hepatitis C, increasing chances of complete cure Thai Rath
Scientific articles 20 Feb 2024 A sample-centric and knowledge-driven computational framework for natural products drug discovery ACS Central Science
Scientific articles 31 Jan 2024 Onchocerciasis drug discovery: In vitro evaluation of FDA-approved drugs against onchocerca gutturosa in Gambia Pharmaceutics
Scientific articles 30 Jan 2024 Late-stage diversification of pyrazoles as antileishmanial agents ChemMedChem
Scientific articles 24 Jan 2024 Generation and evaluation of protease inhibitor-resistant SARS-CoV-2 strains Antiviral Research
Scientific articles 23 Jan 2024 Bioluminescence imaging reveals enhanced SARS-CoV-2 clearance in mice with combinatorial regimens iScience
Scientific articles 21 Jan 2024 Population pharmacokinetics of pediatric lopinavir/ritonavir oral pellets in children living with HIV in Africa Clinical Pharmacology and Therapeutics
Scientific articles 10 Jan 2024 Efficacy and safety of fexinidazole for treatment of chronic indeterminate Chagas disease (FEXI-12): a multicentre, randomised, double-blind, phase 2 trial The Lancet Infectious Diseases
Scientific articles 25 Dec 2023 Madurastatins with imidazolidinone rings: Natural products or side-reaction products from extraction solvents? International Journal of Molecular Sciences
Scientific articles 15 Dec 2023 Facing the escalating burden of dengue: Challenges and perspectives PLOS Global Public Health
Scientific articles 13 Dec 2023 DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc1 Science Translational Medicine
Scientific articles 13 Dec 2023 Short-course combination treatment for experimental chronic Chagas disease Science Translational Medicine
Scientific articles 5 Dec 2023 Estimating the proportion of relapse following treatment of visceral leishmaniasis: meta-analysis using Infectious Diseases Data Observatory (IDDO) systematic review Lancet Regional Health Southeast Asia
Scientific articles 27 Nov 2023 A simulation-based method to inform serosurvey designs for estimating the force of infection using existing blood samples PLOS Computational Biology
Scientific articles 21 Nov 2023 Clinical use of molecular methods for Trypanosoma cruzi infection in endemic and non-endemic countries: Benefits, limitations and challenges Frontiers in Parasitology
Scientific articles 21 Nov 2023 Safety and efficacy of paromomycin/ miltefosine/ liposomal amphotericin B combinations for the treatment of post-kala-azar dermal leishmaniasis in Sudan: A phase II, open label, randomized, parallel arm study PLOS Neglected Tropical Diseases
Scientific articles 21 Nov 2023 Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysis PLOS Medicine
